https://www.selleckchem.com/products/fg-4592.html
athogenesis of LUAD. The findings of the present study suggested that GNPNAT1 upregulation may be considered as a promising diagnostic and prognostic biomarker in patients with LUAD. In addition, the aforementioned pathways may be pivotal pathways perturbed by the abnormal expression of GNPNAT1 in LUAD. The findings of the present study demonstrated the therapeutic value of the regulation of GNPNAT1 in lung adenocarcinoma.The association between the serum levels of cancer antigen 125 (CA125; also termed MUC16) and the prognosis of patie
Aimer
Commentaire
Partagez
